Clinical trial · Observational
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
Increasing the Number of Resected Lymph Nodes Improves Overall Survival of Patients With Esophageal Squamous Cell Carcinoma With Positive Lymph Nodes: a Retrospective Analysis of 1656 Cases at a Single Cancer Center
NCT05570487CI-TRIAL-00061657unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To clarify the effect of the number of lymph node dissection and the number of stations on survival
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| the Records of Esophageal Cancer | Esophageal Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Since the data were collected retrospectively, there were no interventions | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- N0A Group
- description
- patients with negative lymph nodes and resected lymph nodes less than 15
- interventionNames
- Diagnostic Test: Since the data were collected retrospectively, there were no interventions
- label
- N0B Group
- description
- patients with negative lymph nodes and resected lymph nodes no less than 15
- interventionNames
- Diagnostic Test: Since the data were collected retrospectively, there were no interventions
- label
- N+A Group
- description
- patients with positive lymph nodes and resected lymph nodes less than 15
- interventionNames
- Diagnostic Test: Since the data were collected retrospectively, there were no interventions
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: 1. Men and women aged 18-85; 2. Histologically confirmed primary thoracic esophageal squamous cell carcinoma, 3. Staging PT1-4A, N0-3, M0 AJCC eighth edition; 4. Excluding lymph node dissection \< 15,(meeting the guideline criteria) Exclusion Criteria: 1. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux 2. Patients with distant metastasis confirmed by imaging; 3. Patients with obvious surgical contraindications.
References
Publications (2)
- DERIVEDLi K, Leng X, Peng L. Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma in pT2 and pT3. Int J Surg. 2024 Mar 1;110(3):1879-1881. doi: 10.1097/JS9.0000000000001023. No abstract available. PMID 38116658
- DERIVEDLi K, Leng X, He W, Du K, Li C, Liu K, Wang C, Liu G, Li Z, Jiang L, Li K, Zhou Q, Li J, Luo X, Nie X, Lu S, Li H, Fang Q, Xiao W, Han Y, Peng L. Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study. Int J Surg. 2023 Jul 1;109(7):2001-2009. doi: 10.1097/JS9.0000000000000436. PMID 37222685